Julie A. Vetalice, Author at ORTHOWORLD

Orthopaedic Supplier M&A Boosted by Private Equity Backing

Competitive Landscape Mergers & Acquisitions

Supplier companies have been involved in 17 of the 33 mergers and acquisitions that have closed in the orthopaedic space as of August 15, according to our tracking of activity. This activity comes in direct response to device company consolidation.

Aug 29, 2017

Regentis Biomaterials Receives CE Mark Approval for GelrinC Implant

Orthobiologics ORTHOFLASH

Regentis Biomaterials received CE Mark approval for a GelrinC biodegradable implant based on denatured human fibrinogen for the treatment of articular knee cartilage defects.

Aug 28, 2017

Kuros Biosciences Receives Additional FDA 510(k) Clearance for MagnetOs Putty

Orthobiologics ORTHOFLASH

Kuros Biosciences received FDA 510(k) clearance to market MagnetOs synthetic bone graft putty as an autograft extender in the posterolateral spine.

Aug 28, 2017

Medtronic Posts FY1Q18 Revenue Growth

Company Revenue The Numbers

ORTHOWORLD estimates Medtronic’s FY1Q18 revenue at US $728.0MM, +1.0% vs. FY1Q17. (Quarter ended 7/28/17)

Aug 28, 2017

Bone Biologics Expands Relationship with UCLA

Company Updates Competitive Landscape

Bone Biologics entered into an exclusive license agreement with UCLA for global application of NELL-1 protein in the treatment of osteoporosis and trauma, through a technology transfer.

Aug 24, 2017

DePuy Synthes and JointPoint to Co-market Hip Replacement Navigation System

Company Updates Competitive Landscape

DePuy Synthes entered into an exclusive U.S. agreement with JointPoint to co-market a surgical navigation platform for total hip replacement, beginning in 2H17.

Aug 24, 2017